MACC1 expression levels as a novel prognostic marker for colorectal cancer

Hirofumi Yamamoto, Norikatsu Miyoshi, Koshi Mimori, Toshiki Hitora, Masayoshi Tokuoka, Shiki Fujino, Haley L. Ellis, Hideshi Ishii, Shingo Noura, Masayuki Ohue, Masahiko Yano, Yuichiro Doki, Masaki Mori

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Metastasis-associated in colon cancer-1 (MACC1) is key in promoting tumor proliferation and invasion, and is mediated by the hepatocyte growth factor (HGF) and mesenchymal-epithelial transition factor. Previous reports have revealed that MACC1 is a novel oncogene that is expressed in various types of gastrointestinal cancer. The present study comprised of 174 patients who underwent curative surgery for colorectal cancer (CRC). The correlation between gene expression and clinical parameters of the patients was assessed. It was identified that patients exhibiting high MACC1 expression levels were statistically more susceptible to distant metastases and a poor prognosis, and those exhibiting low MACC1 expression showed improved disease-free and overall survival than those with high expression. Therefore, the present data indicates that MACC1 expression levels may present as a prognostic factor in CRC patients.

Original languageEnglish
Pages (from-to)2305-2309
Number of pages5
JournalOncology Letters
Volume8
Issue number5
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Colonic Neoplasms
Colorectal Neoplasms
Neoplasm Metastasis
Gastrointestinal Neoplasms
Epithelial-Mesenchymal Transition
Hepatocyte Growth Factor
Oncogenes
Disease-Free Survival
Gene Expression
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

MACC1 expression levels as a novel prognostic marker for colorectal cancer. / Yamamoto, Hirofumi; Miyoshi, Norikatsu; Mimori, Koshi; Hitora, Toshiki; Tokuoka, Masayoshi; Fujino, Shiki; Ellis, Haley L.; Ishii, Hideshi; Noura, Shingo; Ohue, Masayuki; Yano, Masahiko; Doki, Yuichiro; Mori, Masaki.

In: Oncology Letters, Vol. 8, No. 5, 01.11.2014, p. 2305-2309.

Research output: Contribution to journalArticle

Yamamoto, H, Miyoshi, N, Mimori, K, Hitora, T, Tokuoka, M, Fujino, S, Ellis, HL, Ishii, H, Noura, S, Ohue, M, Yano, M, Doki, Y & Mori, M 2014, 'MACC1 expression levels as a novel prognostic marker for colorectal cancer', Oncology Letters, vol. 8, no. 5, pp. 2305-2309. https://doi.org/10.3892/ol.2014.2460
Yamamoto H, Miyoshi N, Mimori K, Hitora T, Tokuoka M, Fujino S et al. MACC1 expression levels as a novel prognostic marker for colorectal cancer. Oncology Letters. 2014 Nov 1;8(5):2305-2309. https://doi.org/10.3892/ol.2014.2460
Yamamoto, Hirofumi ; Miyoshi, Norikatsu ; Mimori, Koshi ; Hitora, Toshiki ; Tokuoka, Masayoshi ; Fujino, Shiki ; Ellis, Haley L. ; Ishii, Hideshi ; Noura, Shingo ; Ohue, Masayuki ; Yano, Masahiko ; Doki, Yuichiro ; Mori, Masaki. / MACC1 expression levels as a novel prognostic marker for colorectal cancer. In: Oncology Letters. 2014 ; Vol. 8, No. 5. pp. 2305-2309.
@article{15d60047358e495eaf7b94d366313bde,
title = "MACC1 expression levels as a novel prognostic marker for colorectal cancer",
abstract = "Metastasis-associated in colon cancer-1 (MACC1) is key in promoting tumor proliferation and invasion, and is mediated by the hepatocyte growth factor (HGF) and mesenchymal-epithelial transition factor. Previous reports have revealed that MACC1 is a novel oncogene that is expressed in various types of gastrointestinal cancer. The present study comprised of 174 patients who underwent curative surgery for colorectal cancer (CRC). The correlation between gene expression and clinical parameters of the patients was assessed. It was identified that patients exhibiting high MACC1 expression levels were statistically more susceptible to distant metastases and a poor prognosis, and those exhibiting low MACC1 expression showed improved disease-free and overall survival than those with high expression. Therefore, the present data indicates that MACC1 expression levels may present as a prognostic factor in CRC patients.",
author = "Hirofumi Yamamoto and Norikatsu Miyoshi and Koshi Mimori and Toshiki Hitora and Masayoshi Tokuoka and Shiki Fujino and Ellis, {Haley L.} and Hideshi Ishii and Shingo Noura and Masayuki Ohue and Masahiko Yano and Yuichiro Doki and Masaki Mori",
year = "2014",
month = "11",
day = "1",
doi = "10.3892/ol.2014.2460",
language = "English",
volume = "8",
pages = "2305--2309",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - MACC1 expression levels as a novel prognostic marker for colorectal cancer

AU - Yamamoto, Hirofumi

AU - Miyoshi, Norikatsu

AU - Mimori, Koshi

AU - Hitora, Toshiki

AU - Tokuoka, Masayoshi

AU - Fujino, Shiki

AU - Ellis, Haley L.

AU - Ishii, Hideshi

AU - Noura, Shingo

AU - Ohue, Masayuki

AU - Yano, Masahiko

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Metastasis-associated in colon cancer-1 (MACC1) is key in promoting tumor proliferation and invasion, and is mediated by the hepatocyte growth factor (HGF) and mesenchymal-epithelial transition factor. Previous reports have revealed that MACC1 is a novel oncogene that is expressed in various types of gastrointestinal cancer. The present study comprised of 174 patients who underwent curative surgery for colorectal cancer (CRC). The correlation between gene expression and clinical parameters of the patients was assessed. It was identified that patients exhibiting high MACC1 expression levels were statistically more susceptible to distant metastases and a poor prognosis, and those exhibiting low MACC1 expression showed improved disease-free and overall survival than those with high expression. Therefore, the present data indicates that MACC1 expression levels may present as a prognostic factor in CRC patients.

AB - Metastasis-associated in colon cancer-1 (MACC1) is key in promoting tumor proliferation and invasion, and is mediated by the hepatocyte growth factor (HGF) and mesenchymal-epithelial transition factor. Previous reports have revealed that MACC1 is a novel oncogene that is expressed in various types of gastrointestinal cancer. The present study comprised of 174 patients who underwent curative surgery for colorectal cancer (CRC). The correlation between gene expression and clinical parameters of the patients was assessed. It was identified that patients exhibiting high MACC1 expression levels were statistically more susceptible to distant metastases and a poor prognosis, and those exhibiting low MACC1 expression showed improved disease-free and overall survival than those with high expression. Therefore, the present data indicates that MACC1 expression levels may present as a prognostic factor in CRC patients.

UR - http://www.scopus.com/inward/record.url?scp=84907149915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907149915&partnerID=8YFLogxK

U2 - 10.3892/ol.2014.2460

DO - 10.3892/ol.2014.2460

M3 - Article

AN - SCOPUS:84907149915

VL - 8

SP - 2305

EP - 2309

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 5

ER -